Your browser doesn't support javascript.
loading
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer.
Hensing, Whitney L; Gerratana, Lorenzo; Clifton, Katherine; Medford, Arielle J; Velimirovic, Marko; Shah, Ami N; D'Amico, Paolo; Reduzzi, Carolina; Zhang, Qiang; Dai, Charles S; Denault, Elyssa N; Bagegni, Nusayba A; Opyrchal, Mateusz; Ademuyiwa, Foluso O; Bose, Ron; Behdad, Amir; Ma, Cynthia X; Bardia, Aditya; Cristofanilli, Massimo; Davis, Andrew A.
Afiliación
  • Hensing WL; Saint Luke's Cancer Institute, University of Missouri-KC School of Medicine, Kansas City, Missouri.
  • Gerratana L; Department of Medical Oncology-CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy.
  • Clifton K; Department of Medicine, Division of Hematology and Oncology, Washington University in St. Louis, St. Louis, Missouri.
  • Medford AJ; Massachusetts General Hospital, Boston, Massachusetts.
  • Velimirovic M; Massachusetts General Hospital, Boston, Massachusetts.
  • Shah AN; Department of Medicine, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • D'Amico P; Department of Medicine, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Reduzzi C; Weill Cornell Medicine, New York, New York.
  • Zhang Q; Department of Medicine, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Dai CS; Massachusetts General Hospital, Boston, Massachusetts.
  • Denault EN; Massachusetts General Hospital, Boston, Massachusetts.
  • Bagegni NA; Department of Medicine, Division of Hematology and Oncology, Washington University in St. Louis, St. Louis, Missouri.
  • Opyrchal M; Department of Medicine, Division of Hematology and Oncology, Washington University in St. Louis, St. Louis, Missouri.
  • Ademuyiwa FO; Department of Medicine, Division of Hematology and Oncology, Washington University in St. Louis, St. Louis, Missouri.
  • Bose R; Department of Medicine, Division of Hematology and Oncology, Washington University in St. Louis, St. Louis, Missouri.
  • Behdad A; Department of Medicine, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Ma CX; Department of Medicine, Division of Hematology and Oncology, Washington University in St. Louis, St. Louis, Missouri.
  • Bardia A; Massachusetts General Hospital, Boston, Massachusetts.
  • Cristofanilli M; Weill Cornell Medicine, New York, New York.
  • Davis AA; Department of Medicine, Division of Hematology and Oncology, Washington University in St. Louis, St. Louis, Missouri.
Clin Cancer Res ; 29(16): 3092-3100, 2023 08 15.
Article en En | MEDLINE | ID: mdl-37265453
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ADN Tumoral Circulante Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ADN Tumoral Circulante Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article